(NASDAQ: KRRO) Korro Bio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.94%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.52%.
Korro Bio's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast KRRO's revenue for 2027 to be $32,087,784, with the lowest KRRO revenue forecast at $32,087,784, and the highest KRRO revenue forecast at $32,087,784. On average, 1 Wall Street analysts forecast KRRO's revenue for 2028 to be $296,812,002, with the lowest KRRO revenue forecast at $296,812,002, and the highest KRRO revenue forecast at $296,812,002.
In 2029, KRRO is forecast to generate $858,348,222 in revenue, with the lowest revenue forecast at $858,348,222 and the highest revenue forecast at $858,348,222.